XBiotech (XBIT) Stock Highlights

6.38 | +0.63%

2024-12-21 06:13:37

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Statistics

Range Today

6.13 6.66

Volume Today 214.7K

Range 1 Year

3.81 9.96

Volume 1 Year 18.86M

Range 3 Year

3 11.9

Volume 3 Year 47.66M

Range 10 Year

2.13 32.5

Volume 10 Year 361.53M

Highlights

Market Capitalization 194.49M (small)

Floating Shares 19.84M

Current Price 6.38

Price To Earnings -5.81

Price To Book 1.01

Earnings Per Share -1.08

Payout Ratio 0%

Performance

Latest +0.63%

1 Month -3.77%

3 Months -16.6%

6 Months +22.46%

1 Year +55.61%

3 Years -43.64%

5 Years -67.47%

10 Years -72.26%

Benchmarks

Market Capitalization

229 / 368

Gross Profits

111 / 278

Total Revenue

264 / 300

Total Rank

69 / 368

Free Cashflow

119 / 352

Performance 5 years

192 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.